DANAOS CORPORATION (DAC) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value 1.61%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.61% | Share-based compensation / revenue. Period ending 2025-12-31. $16.75M ÷ $1.04B × 100 ≈ 1.61% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 1.04B USD | |
| Stock-based compensation | 16.75M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 498.77M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | (m) | $1.04B | $16.75M | $498.77M | (m) | (m) | 1.61% | (m) | (m) |
| 2025-06-30 | (m) | $1.03B | $14.83M | $506.26M | (m) | (m) | 1.44% | (m) | (m) |
| 2024-12-31 | (m) | $1.01B | $14.56M | $540.88M | (m) | (m) | 1.44% | (m) | (m) |
| 2024-06-30 | (m) | $988.28M | (m) | $558.98M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $973.58M | $12.68M | $580.66M | $20.46M | (m) | 1.30% | 28.38× | Reported |
| 2023-06-30 | (m) | $997.57M | (m) | $658.64M | $41.55M | (m) | (m) | 15.85× | Reported |
| 2022-12-31 | (m) | $993.34M | $5.97M | $653.44M | $62.14M | (m) | 0.60% | 10.52× | Reported |
| 2022-06-30 | (m) | $891.78M | $10.05M | $524.78M | $68.87M | (m) | 1.13% | 7.62× | Reported |
| 2021-12-31 | (m) | $689.50M | $15.28M | $358.26M | $68.99M | (m) | 2.22% | 5.19× | Reported |
| 2021-06-30 | (m) | $517.13M | $6.08M | $235.67M | $56.86M | (m) | 1.18% | 4.14× | Reported |
| 2020-12-31 | (m) | $461.59M | $1.20M | $199.48M | $53.50M | (m) | 0.26% | 3.73× | Reported |
| 2020-06-30 | (m) | $445.05M | $2.97M | $194.63M | $65.34M | (m) | 0.67% | 2.98× | Reported |
| 2019-12-31 | (m) | $447.24M | $4.24M | $201.07M | $72.07M | (m) | 0.95% | 2.79× | Reported |
| 2019-06-30 | (m) | $458.62M | (m) | $-7.92M | $76.52M | (m) | (m) | -0.10× | Reported |
| 2018-12-31 | (m) | $458.73M | $1.01M | $-12.12M | $85.71M | (m) | 0.22% | -0.14× | Reported |
| 2018-06-30 | (m) | $453.08M | (m) | $194.58M | $90.11M | (m) | (m) | 2.16× | Reported |
| 2017-12-31 | (m) | $451.73M | (m) | $187.50M | $86.56M | (m) | (m) | 2.17× | Reported |
| 2017-06-30 | (m) | $447.83M | (m) | $-256.95M | $84.50M | (m) | (m) | -3.04× | Reported |
| 2016-12-31 | (m) | $498.33M | $76.00K | $-212.64M | $82.97M | (m) | 0.02% | -2.56× | Reported |
| 2016-06-30 | (m) | $562.34M | (m) | $239.10M | $68.06M | (m) | (m) | 3.51× | Reported |
| 2015-12-31 | (m) | $567.94M | $88.00K | $244.38M | $70.40M | (m) | 0.02% | 3.47× | Reported |
| 2015-06-30 | (m) | $560.24M | (m) | $200.29M | $74.64M | (m) | (m) | 2.68× | Reported |
| 2014-12-31 | (m) | $552.09M | $638.00K | $192.41M | $79.98M | (m) | 0.12% | 2.41× | Reported |
| 2014-06-30 | (m) | $567.38M | (m) | $258.46M | $86.29M | (m) | (m) | 3.00× | Reported |
| 2013-12-31 | (m) | $588.12M | $75.00K | $272.47M | $91.19M | (m) | 0.01% | 2.99× | Reported |
| 2013-06-30 | (m) | $600.78M | (m) | $163.63M | $93.65M | (m) | (m) | 1.75× | Reported |
| 2012-12-31 | (m) | $589.01M | $139.00K | $152.96M | $87.34M | (m) | 0.02% | 1.75× | Reported |
| 2012-06-30 | (m) | $535.24M | $2.17M | $247.09M | $70.16M | (m) | 0.40% | 3.52× | Reported |
| 2011-12-31 | (m) | $468.10M | $2.18M | $205.20M | $55.12M | (m) | 0.47% | 3.72× | Reported |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $359.68M | $1.69M | $86.16M | $41.16M | (m) | 0.47% | 2.09× | Reported |
| 2009-12-31 | (m) | $319.51M | $47.00K | $136.10M | $36.21M | (m) | 0.01% | 3.76× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.